InsiderTrades

Form 4 for ICE Intercontinental Exchange

Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-17 · accession 0000950170-25-042048 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-03-19 2025-03-17 ICE Jackson Benjamin Pres M - OptEx $71.29 +2,805 148.8K +2% +$200.0K
DM 2025-03-19 2025-03-17 ICE Jackson Benjamin Pres M - OptEx $0.00 -2,805 34.3K -8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-17 M A 1,313 $76.16 150,079 D — — (F1) The common stock number referred in Table I is an aggregate number and represents 122,444 shares of common stock and 9,424 unvested restricted stock units ("RSUs"), and 18,211 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. (F3) The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. (F2) The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting.
2 Common Common Stock 2025-03-17 M A 1,492 $67.00 148,766 D — —
3 Derivative Employee Stock Option (right to buy) Holding 2025-03-17 M D 1,492 $0.00 37,849 D $67.00 · — to 2028-02-08 1,492 Common Stock (F4) These options are fully vested
4 Derivative Employee Stock Option (right to buy) Holding 2025-03-17 M D 1,313 $0.00 34,285 D $76.16 · — to 2029-02-08 1,313 Common Stock (F4) These options are fully vested